retatrutide trial news New Phase 3 data just dropped π Eli Lilly's reported average weight loss approaching 30%, with some patients achieving results historically associated with bariatric surgery. A few important caveats Retatrutide Results: 28.3% Weight Loss
Description
Serious stomach or bowel problems like gastroparesis, as GLP-1 use can make these issues worse
Research from the Employee Benefit Research Institute projects that broad GLP-1 coverage could increase employer health plan premiums by six to fourteen percent, depending on eligibility criteria and patient adherence
Cell 133 WangX.OlsonJ
[2] The researchers theorized that slower caffeine clearance impairs adenosine-mediated coronary vasodilation during exercise, reducing myocardial blood flow when it's most needed
Ferrannini G, Gerstein H, Colhoun HM, Dagenais GR, Diaz R, Dyal L, et al
Second, these windows represent maximum allowed time, not optimal time
